A Japan DMAH (Designated Marketing Authorization Holder) manages post-market surveillance by monitoring product safety, collecting and analyzing adverse event data, and ensuring compliance with regulatory requirements. They report findings to the Pharmaceuticals and Medical Devices Agency (PMDA) and implement corrective actions to maintain product safety and efficacy in the Japanese market.
